Polynucleotide enrichment and amplification using CRISPR-Cas or Argonaute systems

US12391983B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12391983-B2
Application numberUS-202218063865-A
CountryUS
Kind codeB2
Filing dateDec 9, 2022
Priority dateMay 11, 2016
Publication dateAug 19, 2025
Grant dateAug 19, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for enriching or amplifying a target nucleic acid including providing a system having a guide nucleic acid, and a Cas or Argonaute protein or a variant thereof. The guide nucleic acid contains a target-specific nucleotide region substantially complementary to a region of the target nucleic acid, and contacting the target nucleic acid with the system to form a complex.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing a library of nucleic acids, comprising: (i) tagmenting a double-stranded target nucleic acid to obtain a plurality of double-stranded fragments, wherein a first strand of each double-stranded fragment contains a universal sequence; and (ii) amplifying the plurality of double-stranded fragments, comprising: (a) providing a system comprising: a 5′ phosphorylated single-stranded nucleic acid, and an Argonaute protein, wherein the 5′ phosphorylated single-stranded nucleic acid comprises a sequence complementary to a region of the universal sequence, (b) contacting the plurality of double-stranded fragments with the system to form a plurality of complexes, wherein each complex comprises the 5′ phosphorylated single-stranded nucleic acid hybridized to the first strand, and a displaced region of a second strand of a double-stranded fragment of the plurality of double-stranded fragments, wherein the displaced region comprises a loop, (c) hybridizing a primer to the displaced region, wherein the primer comprises a sequence complementary to the displaced region, and (d) extending the hybridized primer with a polymerase. 2. The method of claim 1 , wherein the tagmenting comprises contacting the target nucleic acid with a transposome comprising a transposase and a nucleic acid comprising the universal sequence. 3. The method of claim 1 , wherein the amplification is linear. 4. The method of claim 1 , wherein the amplification is exponential. 5. The method of claim 1 , wherein the polymerase is a strand-displacing polymerase. 6. The method of claim 1 , wherein the target nucleic acid is a double-stranded DNA or a double-stranded RNA. 7. The method of claim 1 , wherein the 5′ phosphorylated single-stranded nucleic acid is a single-stranded DNA having a length of 25 nucleotides or less. 8. The method of claim 2 , wherein the transposase is selected from a hyperactive Tn5 transposase or a MuA transposase. 9. The method of claim 1 , further comprising (e) sequencing the extended primer. 10. The method of claim 1 , wherein the system is bound to a surface. 11. The method of claim 10 , wherein a plurality of beads comprises the surface. 12. The method of claim 10 , wherein a flow cell comprises the surface. 13. The method of claim 3 , wherein the amplification is performed under isothermal conditions. 14. The method of claim 1 , wherein the polymerase is selected from the group consisting of a Bst polymerase, a Bsu polymerase, and a Phi29 polymerase. 15. The method of claim 1 , wherein the Argonaute protein is Natronobacterium gregorgi Argonaute. 16. The method of claim 1 , wherein the universal sequence comprises a nucleotide sequence selected from any one of SEQ ID NOs: 01-06. 17. The method of claim 1 , wherein the double-stranded target nucleic acid comprises genomic DNA. 18. A method for preparing a library of nucleic acids, comprising: (i) tagmenting a double-stranded target nucleic acid to obtain a plurality of double-stranded fragments, wherein a first strand of each double-stranded fragment contains a universal sequence, wherein the double-stranded target nucleic acid is a double-stranded RNA; and (ii) amplifying the plurality of double-stranded fragments, comprising: (a) providing a system comprising: a 5′ phosphorylated single-stranded nucleic acid, and an Argonaute protein, wherein the 5′ phosphorylated single-stranded nucleic acid comprises a sequence complementary to a region of the universal sequence, (b) contacting the plurality of double-stranded fragments with the system to form a plurality of complexes, wherein each complex forms a loop comprising the 5′ phosphorylated single-stranded nucleic acid hybridized to the first strand, and a displaced region of a second strand of a double-stranded fragment of the plurality of double-stranded fragments, (c) hybridizing a primer to the displaced region, wherein the primer comprises a sequence complementary to the displaced region, and (d) extending the hybridized primer with a polymerase.

Assignees

Inventors

Classifications

  • Polymerase chain reaction [PCR] · CPC title

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • C12Q1/6844Primary

    Nucleic acid amplification reactions · CPC title

  • Linear amplification, i.e. non exponential · CPC title

  • Single or double stranded nucleic acid binding proteins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12391983B2 cover?
A method for enriching or amplifying a target nucleic acid including providing a system having a guide nucleic acid, and a Cas or Argonaute protein or a variant thereof. The guide nucleic acid contains a target-specific nucleotide region substantially complementary to a region of the target nucleic acid, and contacting the target nucleic acid with the system to form a complex.
Who is the assignee on this patent?
Illumina Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).